Quantum BioPharma Ltd. (QNTM) is pleased to announce that after receiving approval from the Board of Directors, the company purchased USD $1,000,000 worth of Bitcoin (BTC) and other cryptocurrencies as part of its strategic efforts. Additionally, in the future, the Company will allow future financing and other transactions to be conducted in cryptocurrency.
This move reflects the company’s belief in the potential of Bitcoin (BTC) and other currencies to provide a return on investment to shareholders. The company is now created to receive cryptocurrency financing, as well as to execute other types of cryptocurrency transactions.
The company keeps all of its cryptocurrencies with a fully compliant custodian. The company emphasizes that all transactions comply and will fully comply with all relevant financial and audit regulations, ensuring a safe and legal process.
The Company will continue to monitor market conditions and may increase or decrease its holdings of Bitcoin (BTC) or other cryptocurrencies as it deems appropriate.
“We are exploring innovative ways to grow our capital without using it in operations,” said Zeeshan Saeed, CEO of Quantum. “Bitcoin’s recent advances in legal and market legitimacy make it a compelling addition. With multiple global asset managers now offering BTC-based exchange-traded funds and renewed optimism following expectations of pro-crypto policies under the new administration of President-elect Donald Trump, we believe Bitcoin (BTC) and other cryptocurrencies present an opportunity to align with emerging financial trends.”
